key: cord-0712898-qgtcpnwd
authors: Ross, Jennifer A.; Malone, Patrice K.; Levy, Sharon
title: The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US
date: 2022-04-27
journal: Clin Infect Dis
DOI: 10.1093/cid/ciac311
sha: a546d1db934e5279429c5e3568a3ef52cda71223
doc_id: 712898
cord_uid: qgtcpnwd

The SARS-CoV-2 pandemic has been associated with dramatic increases in substance use, as marked by increased alcohol, nicotine and cannabis sales. Lethal opioid overdoses also increased dramatically, especially during the initial phases of the epidemic when lockdowns and social isolation combined with increasing fentanyl contamination of the illicit drug supply resulted in more overdoses and fewer opportunities for rescue. Substance use, and especially inhalational drug use, increases the likelihood of both transmission and severe infection. Youth are especially vulnerable to substance use and have increased risk of long-term problems. These outcomes highlight the need for greater access to substance use treatment. Virtual treatment, which emerged as a promising format during the pandemic, may reduce access barriers. This manuscript reviews trends in substance use during the pandemic, explores root causes of increased use and overdose and examines the potential to increase treatment through virtual care, especially during future periods of disruption.

The SARS-CoV-2 pandemic has exposed and exacerbated the challenges faced by 2 vulnerable populations including individuals with substance use disorders (SUD). 1,2 Disasters of 3 the past have been linked to increased alcohol, tobacco, and cannabis use, and the SARS-CoV-2 4 pandemic is no exception. 3, 4 Measures to curb the spread of coronavirus have led to unintended 5 negative consequences, including isolation increased stress and anxiety, all of which are factors 6 that can lead to substance use. 5, 6 Additionally, access to medical care and other supports and 7 treatments were also limited during the SARS-CoV-2 pandemic. The increase in substance use 8 and resulting development of SUD during the pandemic, especially among youth, has large 9 implications for public health 7,8 and also the economy. 10 Increases in alcohol, nicotine and cannabis use during the SARS-CoV-2 pandemic 11 Many individuals use psychoactive substances as coping mechanisms, including for 12 mitigation of stress caused by the SARS-CoV-2 pandemic. 8, 9 In June 2020, 13% of adults aged > 13 18 years across the United States (US) reported starting or increasing substance use to cope with 14 stress or emotions. 10 Alcohol is the most commonly used depressant psychoactive substance in 15 the US. Stay-at-home orders and lockdowns contributed to increased alcohol consumption. 11 In 16 the US, liquor stores were deemed essential businesses and remained open during the pandemic, 17 with alcohol sales increasing substantially. 12,13 Increased alcohol sales during lockdowns raised 18 concern for increased at-home drinking, as public locations such as bars were closed. 14 This 19 increased consumption has led to increased at-risk drinking, sometimes referred to as "gray area 20 drinking", in which a person does not meet criteria for alcohol use disorder but consumes enough 21 alcohol to negatively impact health. 15 Increases in overall alcohol consumption have been 22 particularly notable in women 16 and young adults. 17 Lockdowns have also been associated with 23 A C C E P T E D M A N U S C R I P T increased binge drinking, 18 and more adolescent alcohol use at home, often permitted by parents, 1 and sometimes for children as young as 13 years of age. 19 Initiation of alcohol use in early 2 adolescence has been linked to increased risk of binge drinking and alcohol use disorder later in 3 life. In the US, more than 90,000 deaths annually are attributed to alcohol use, with an average of 4 29 years of life lost per death for a total of 2.7 million years of potential life lost. 20 Costs to the 5 economy include those from loss of workplace productivity and healthcare. In 2010, the CDC 6 estimated that the cost of excessive alcohol use is more than $2 per drink. 21 Increased alcohol use 7 during the pandemic will have enormous financial costs and act as a substantial hindrance to the 8 economic recovery.

Increased stress is also associated with increased tobacco and nicotine use. 22 Similarly to 10 alcohol, tobacco sales increased during the pandemic. 13 The popularity of e-cigarettes has led to 11 nicotine use in many individuals who were previously non-smokers, including among young 12 adults. 23 E-cigarette use had been increasing in popularity prior to the SARS-CoV-2 pandemic, 13 with an estimated 2.3% of all US adults reporting current vaping. 23 In August 2019, the Centers 14 for Disease Control and Prevention (CDC) received report of a case of E-cigarette, or Vaping, 15 product use-Associated Lung Injury, or EVALI. This vaping epidemic overlapped with the 16 beginnings of the SARS-CoV-2 pandemic, and by February 2020 there were 2807 EVALI cases 17 and 68 deaths. 24 E-cigarette use continues to be popular, with extension of use into younger 18 populations. Per the National Youth Tobacco Survey in 2021, 11.3% of high school students and 19 2.8% of middle school students currently use e-cigarettes, for a total of more than 2 million 20 youths. 25 Tobacco product use is a financial burden, with 5.1 million years of potential life lost 21 and $96.8 billion in productivity losses annually in the US. 26

is a risk factor for increased cannabis use. 5 By 2020, when stay-at-home orders for the pandemic 2 were put in place, 27 states had decriminalized cannabis possession and 11 states had legalized 3 adult recreational cannabis use. 27 As the pandemic evolved, more states began to pass laws 4 legalizing cannabis, even while cannabis remained federally illegal. 28 As of August 2021, 47 5 states have at least some form of cannabis legalization, with 18 states and the District of 6 Columbia legalizing both medical and adult recreational cannabis use. 28 Compared to those who 7 did not isolate, young adults who self-isolated during the pandemic had greater cannabis use. 5 Relationship between pandemic and overdose deaths 17 The syndemic of drug related overdose deaths and the SARS-CoV-2 pandemic continues 18 to be troubling and relentless. An estimated 81,230 deaths occurred secondary to drug overdoses 19 from June 2019 through May of 2020, which constituted an 18% increase from the year before, 20 with a steep increase specifically in April and May of 2020. 36 In total, the public health crisis 21 triggered by coronavirus has exacerbated the already resource-challenged behavioral health 

Of particular concern for youth during the SARS-CoV-2 pandemic is the risk of 16 substance use initiation and escalation. Early initiation of substance use is associated with 17 immediate and later life negative outcomes including violence, poor physical health, delinquent 18 behavior, mental health problems and addiction. A Canadian study found that overall the 19 percentage of youth using substances decreased during the pandemic as fewer youth initiated 20 substance use during the initial periods of lockdown and school closures during which peer 21 contact was decreased significantly and access to substances was likely more limited. However, 22 the frequency of cannabis and alcohol use increased among those who were already using these

substances. The study also found substantial face-to-face substance use with peers despite stay at 1 home orders particularly for youth who assessed their popularity as "low". On the contrary, 2 solitary substance use, also a risk factor for substance use disorders, was reported mostly by 3 those with depression, fear of contracting coronavirus, or youth who self-rated their popularity as 4 average to high popularity. 48 As the pandemic has progressed, substance use has remained 5 relatively stable among youth with those at highest risk being older, out of school, and residing 6 outside of the parental/guardian home. 49 While most of the data available at this time has 7 provided a snap shot of adolescent substance use early in the pandemic, it is possible that 8 initiation rates may rebound as students return to school while stress remains high due to the 9 ongoing pandemic. Extended longitudinal research could be quite enlightening as adolescents 10 develop into adults and physical and mental health outcomes can be followed. As the SARS-

CoV-2 pandemic has already had several surges with restrictions increased and later relaxed 12 along with widespread vaccine distribution, it will be crucial to follow youth and others over the Access to medical care overall has been a concern during the pandemic as COVID-19 cases 17 rose, the health care system became overburdened, and our medical teams grew more fatigued.

As the treatment of those with COVID-19 disease was prioritized, routine care and treatment of 19 non-SARS-CoV-2 related illnesses were delayed and/or not tended to, especially during the billions of dollars of productivity losses, recovery from the SARS-CoV-2 pandemic will require 10 addressing these issues. 

Q & A on Latest Monthly Estimates of Drug Overdose Deaths

COVID-19 Pandemic Impact on Patients, Families & 9 Individuals in Recovery from a SUD

Factors Associated With Drug Overdoses 13 During the COVID-19 Pandemic

Comparison of Characteristics of Deaths 16

From Drug Overdose Before vs During the COVID-19 Pandemic in Rhode Island

Trends in Overall and Non-COVID-19 Hospital Admissions

Out-of-hospital cardiac arrest during the COVID-19

a population-based, observational study

From Accidental Overdose Associated With Psychiatric and Substance Use Disorders

Mental Illness and Psychotropic 9

Drug Use Among Prescription Drug Overdose Deaths: A Medical Examiner Chart Review

Organizations in New York Resulting from COVID-19: A Qualitative Analysis

Care during COVID-19: Drug use, harm reduction, and intimacy 15 during a global pandemic

Overdose Deaths Accelerating During COVID-18 19. CDC Newsroom

Related Predictors

Youth in a pandemic: a longitudinal examination 5 of youth mental health and substance use concerns during COVID-19

Changes in methadone take-home dosing 8 before and after COVID-19

Telehealth mental health services during COVID-19: 11 summary of evidence and clinical practice

Substance Use Disorders and Telehealth in the 14 COVID-19 Pandemic Era

Virtual Care in an Outpatient Subspecialty Substance 17

Use Disorder Treatment Program